Ignite Creation Date:
2024-05-06 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06125223
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-09
First Post:
2023-10-31
Brief Title:
PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma
Sponsor:
Xijing Hospital
Organization:
Xijing Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Squamous Cell Carcinoma of Head and Neck |
| Neoadjuvant Therapy |
| Immunotherapy |
Keywords: